Clene Inc (NAS:CLNN)
$ 0.3865 -0.0005 (-0.13%) Market Cap: 49.64 Mil Enterprise Value: 48.30 Mil PE Ratio: 0 PB Ratio: 3.83 GF Score: 38/100

Clene Inc. at Canaccord Genuity Growth Conference Transcript

Aug 10, 2023 / 03:30PM GMT
Release Date Price: $0.6643 (-4.83%)
Sumant Kulkarni
Canaccord Genuity LLC - Analyst

(technical difficulty) I'm Sumant Kulkarni, a senior biotechnology analyst here at Canaccord Genuity. It's my pleasure to have Clene Nanomedicine here at what is a really interesting time for the company. They've had some intriguing data with their product. Their approach is extremely different.

With that, I'll turn it over to CEO, Rob Etherington. We also have CFO, Morgan Brown, in the audience. Rob will give us a few opening remarks first 10 minutes or so and run us through this Clene story, and we'll have an interactive Q&A. (Conference Instructions)

With that, Rob?

Rob Etherington
Clene Inc. - President & CEO

Thanks, Sumant. It's pleasure to be here today. Very grateful to be invited to the Canaccord Growth Conference.

So forward-looking statement as you've certainly seen before. The number of forward-looking statements that I will make in the course of this next presentation. And we have no need to correct them necessarily. They are forward looking.

So what we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot